26-A-13919-ACC VUTRISIRAN REDUCES THE RISK OF DEVELOPING ADVANCED DISEASE AND DEMONSTRATES BENEFIT IN PATIENTS WHO DEVELOP ADVANCED DISEASE IN ATTR-CM: ANALYSIS FROM THE HELIOS-B STUDY